Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies with a 5-year survival rate less than 8%, which has remained unchanged over the last 50 years. Early detection is particularly difficult due to the lack of disease-specific symptoms and a reliable biomarker. Multimoda...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortoglou, Maria, Tabin, Zoey Kathleen, Arisan, E. Damla, Kocher, Hemant M, Uysal-Onganer, Pinar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042452/
https://www.ncbi.nlm.nih.gov/pubmed/33831655
http://dx.doi.org/10.1016/j.tranon.2021.101090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042452/
https://www.ncbi.nlm.nih.gov/pubmed/33831655
http://dx.doi.org/10.1016/j.tranon.2021.101090

Ejemplares similares